Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (Weighted Average) (2020 - 2025)

Rapid Micro Biosystems' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $44.5 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 1.98% year-over-year to $44.5 million; the TTM value through Sep 2025 reached $44.5 million, up 1.98%, while the annual FY2024 figure was $43.6 million, 1.28% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $44.5 million at Rapid Micro Biosystems, roughly flat from $44.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $44.5 million in Q3 2025 and bottomed at $641371.0 in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $42.9 million (2023), against an average of $37.1 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 9866.7% in 2021 before it rose 1.01% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $19.8 million in 2021, then skyrocketed by 114.59% to $42.5 million in 2022, then grew by 1.34% to $43.0 million in 2023, then rose by 1.28% to $43.6 million in 2024, then increased by 2.2% to $44.5 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Shares Outstanding (Weighted Average) are $44.5 million (Q3 2025), $44.3 million (Q2 2025), and $44.0 million (Q1 2025).